Virus-Like Particles Presenting the FGF-2 Protein or Identified Antigenic Peptides Promoted Antitumor Immune Responses in Mice

Congyan Shu,1 Pengyan Sun,2 Hanghang Xie,3 Weiwei Huang,3 Jialong Qi,3 Yanbing Ma3 1Sichuan Institute for Food and Drug Control, Chengdu, 611731, People’s Republic of China; 2Yunnan Center for Disease Control and Prevention, Kunming 650022, People’s Republic of China; 3Institute...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Shu C, Sun P, Xie H, Huang W, Qi J, Ma Y
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	fibroblast growth factor-2 virus-like particle (vlp) anticytokine active immunization tumor immune response Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/ec5b29e806cc498eb8875bf76084336e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:ec5b29e806cc498eb8875bf76084336e
record_format	dspace
spelling	oai:doaj.org-article:ec5b29e806cc498eb8875bf76084336e2021-12-02T09:36:26ZVirus-Like Particles Presenting the FGF-2 Protein or Identified Antigenic Peptides Promoted Antitumor Immune Responses in Mice1178-2013https://doaj.org/article/ec5b29e806cc498eb8875bf76084336e2020-03-01T00:00:00Zhttps://www.dovepress.com/virus-like-particles-presenting-the-fgf-2-protein-or-identified-antige-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Congyan Shu,1 Pengyan Sun,2 Hanghang Xie,3 Weiwei Huang,3 Jialong Qi,3 Yanbing Ma3 1Sichuan Institute for Food and Drug Control, Chengdu, 611731, People’s Republic of China; 2Yunnan Center for Disease Control and Prevention, Kunming 650022, People’s Republic of China; 3Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Kunming 650118, People’s Republic of ChinaCorrespondence: Yanbing MaLaboratory of Molecular Immunology, Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming 650118, People’s Republic of ChinaTel +86 871 68339287Fax +86 871 68334483Email yanbingma@126.comBackground: Fibroblast growth factor (FGF)-2 is overexpressed in various tumor tissues. It affects tumor cell proliferation, invasion and survival, promotes tumor angiogenesis and is tightly involved in the development of systemic and local immunosuppressive tumor mechanisms.Purpose: This study aimed to develop an effective vaccine against FGF-2 and to investigate the effects of anti-FGF-2 immunization on tumor growth and antitumor immune responses.Methods: A set of thirteen synthesized overlapping peptides covering all possible linear B-cell epitopes of murine FGF-2 and a recombinant FGF-2 protein were conjugated to virus-like particles (VLPs) of recombinant hepatitis B core antigen (HBcAg). The VLPs were immunized through a preventive or therapeutic strategy in a TC-1 or 4T1 grafted tumor model.Results: Immunization with FGF-2 peptides or full-length protein-coupled VLPs produced FGF-2-specific antibodies with a high titer. Peptide 12, which is located in the heparin-binding site of FGF-2, or protein-conjugated VLPs presented the most significant effects on the suppression of TC-1 tumor growth. The levels of IFN-γ-expressing splenocytes and serum IFN-γ were significantly elevated; further, the immune effector cells CD8+ IFN-γ+ cytotoxic T lymphocytes (CTLs) and CD4+ IFN-γ+ Th1 cells were significantly increased, whereas the immunosuppressive cells CD4+ CD25+ FOXP3+ Treg cells and Gr-1+ CD11b+ myeloid-derived suppressor cells (MDSCs) were decreased in the immunized mice. In addition, VLP immunization significantly suppressed tumor vascularization and promoted tumor cell apoptosis. In mice bearing 4T1 breast tumor, preventive immunization with FGF-2-conjugated VLPs suppressed tumor growth and lung metastasis, and increased effector cell responses.Conclusion: Active immunization against FGF-2 is a new possible strategy for tumor immunotherapy.Keywords: fibroblast growth factor-2, virus-like particle, VLP, anticytokine active immunization, tumor, immune responseShu CSun PXie HHuang WQi JMa YDove Medical Pressarticlefibroblast growth factor-2virus-like particle (vlp)anticytokine active immunizationtumorimmune responseMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 15, Pp 1983-1996 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	fibroblast growth factor-2 virus-like particle (vlp) anticytokine active immunization tumor immune response Medicine (General) R5-920
spellingShingle	fibroblast growth factor-2 virus-like particle (vlp) anticytokine active immunization tumor immune response Medicine (General) R5-920 Shu C Sun P Xie H Huang W Qi J Ma Y Virus-Like Particles Presenting the FGF-2 Protein or Identified Antigenic Peptides Promoted Antitumor Immune Responses in Mice
description	Congyan Shu,1 Pengyan Sun,2 Hanghang Xie,3 Weiwei Huang,3 Jialong Qi,3 Yanbing Ma3 1Sichuan Institute for Food and Drug Control, Chengdu, 611731, People’s Republic of China; 2Yunnan Center for Disease Control and Prevention, Kunming 650022, People’s Republic of China; 3Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Kunming 650118, People’s Republic of ChinaCorrespondence: Yanbing MaLaboratory of Molecular Immunology, Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming 650118, People’s Republic of ChinaTel +86 871 68339287Fax +86 871 68334483Email yanbingma@126.comBackground: Fibroblast growth factor (FGF)-2 is overexpressed in various tumor tissues. It affects tumor cell proliferation, invasion and survival, promotes tumor angiogenesis and is tightly involved in the development of systemic and local immunosuppressive tumor mechanisms.Purpose: This study aimed to develop an effective vaccine against FGF-2 and to investigate the effects of anti-FGF-2 immunization on tumor growth and antitumor immune responses.Methods: A set of thirteen synthesized overlapping peptides covering all possible linear B-cell epitopes of murine FGF-2 and a recombinant FGF-2 protein were conjugated to virus-like particles (VLPs) of recombinant hepatitis B core antigen (HBcAg). The VLPs were immunized through a preventive or therapeutic strategy in a TC-1 or 4T1 grafted tumor model.Results: Immunization with FGF-2 peptides or full-length protein-coupled VLPs produced FGF-2-specific antibodies with a high titer. Peptide 12, which is located in the heparin-binding site of FGF-2, or protein-conjugated VLPs presented the most significant effects on the suppression of TC-1 tumor growth. The levels of IFN-γ-expressing splenocytes and serum IFN-γ were significantly elevated; further, the immune effector cells CD8+ IFN-γ+ cytotoxic T lymphocytes (CTLs) and CD4+ IFN-γ+ Th1 cells were significantly increased, whereas the immunosuppressive cells CD4+ CD25+ FOXP3+ Treg cells and Gr-1+ CD11b+ myeloid-derived suppressor cells (MDSCs) were decreased in the immunized mice. In addition, VLP immunization significantly suppressed tumor vascularization and promoted tumor cell apoptosis. In mice bearing 4T1 breast tumor, preventive immunization with FGF-2-conjugated VLPs suppressed tumor growth and lung metastasis, and increased effector cell responses.Conclusion: Active immunization against FGF-2 is a new possible strategy for tumor immunotherapy.Keywords: fibroblast growth factor-2, virus-like particle, VLP, anticytokine active immunization, tumor, immune response
format	article
author	Shu C Sun P Xie H Huang W Qi J Ma Y
author_facet	Shu C Sun P Xie H Huang W Qi J Ma Y
author_sort	Shu C
title	Virus-Like Particles Presenting the FGF-2 Protein or Identified Antigenic Peptides Promoted Antitumor Immune Responses in Mice
title_short	Virus-Like Particles Presenting the FGF-2 Protein or Identified Antigenic Peptides Promoted Antitumor Immune Responses in Mice
title_full	Virus-Like Particles Presenting the FGF-2 Protein or Identified Antigenic Peptides Promoted Antitumor Immune Responses in Mice
title_fullStr	Virus-Like Particles Presenting the FGF-2 Protein or Identified Antigenic Peptides Promoted Antitumor Immune Responses in Mice
title_full_unstemmed	Virus-Like Particles Presenting the FGF-2 Protein or Identified Antigenic Peptides Promoted Antitumor Immune Responses in Mice
title_sort	virus-like particles presenting the fgf-2 protein or identified antigenic peptides promoted antitumor immune responses in mice
publisher	Dove Medical Press
publishDate	2020
url	https://doaj.org/article/ec5b29e806cc498eb8875bf76084336e
work_keys_str_mv	AT shuc viruslikeparticlespresentingthefgf2proteinoridentifiedantigenicpeptidespromotedantitumorimmuneresponsesinmice AT sunp viruslikeparticlespresentingthefgf2proteinoridentifiedantigenicpeptidespromotedantitumorimmuneresponsesinmice AT xieh viruslikeparticlespresentingthefgf2proteinoridentifiedantigenicpeptidespromotedantitumorimmuneresponsesinmice AT huangw viruslikeparticlespresentingthefgf2proteinoridentifiedantigenicpeptidespromotedantitumorimmuneresponsesinmice AT qij viruslikeparticlespresentingthefgf2proteinoridentifiedantigenicpeptidespromotedantitumorimmuneresponsesinmice AT may viruslikeparticlespresentingthefgf2proteinoridentifiedantigenicpeptidespromotedantitumorimmuneresponsesinmice
_version_	1718398096839278592

Virus-Like Particles Presenting the FGF-2 Protein or Identified Antigenic Peptides Promoted Antitumor Immune Responses in Mice

Ejemplares similares